Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, has launched ProPhet, a startup using artificial intelligence to locate small molecules for drug discovery.ProPhet was established following AION Labs’…
Continue Reading
Pharmaceutical company Tolmar has partnered with direct-to-consumer telehealth company UpScriptHealth to provide telehealth consultations for Jatenzo, an oral testosterone-replacement therapy (TRT) for adult men.Tolmar, which acquired Jatenzo in 2022, is positioning the TRT treatment…
Continue Reading
The first day of the HLTH2024 event is done and boy what a conference it has been so far!The diversity of speakers and attendees has been off-the-charts. Payers, providers, pharma, patients, medical device makers,…
Continue Reading
Christopher Wooden, Senior Director, Business Marketing, IQVIA
A critical aspect of any pharma/life sciences commercialization strategy is to develop and deploy effective and meaningful ways to engage, inform and build trust with healthcare providers (HCPs)….
Continue Reading
HLTH 2024 at the Venetian Expo Center in Las Vegas on October 20 to 23 will spotlight a variety of startups that want to improve care coordination for providers, detect diseases earlier, improve the…
Continue Reading
HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight the evolving roles of AI, the shifting landscapes of telemedicine, retail health, women’s health, mental health, innovative care…
Continue Reading
Big data analysis is an invaluable resource in healthcare and life sciences. Data can tell a pharmaceutical company which drugs a medical specialist prescribes and where they are based. This knowledge is key to…
Continue Reading
Daniel Avancini, Chief Data Officer and co-founder of Indicium
Managing data effectively can be challenging in any context. But it’s especially difficult in an industry like pharmaceuticals, due both to the sensitivity of the data…
Continue Reading
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, has secured $100 million in Series F funding and announced Mike Alvarez as the company’s newly appointed CEO. Georgian led the…
Continue Reading
AI biotech company Owkin announced a partnership with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.According to Owkin, BRCA…
Continue Reading
